Display Settings:

Format

Send to:

Choose Destination
    Radiology. 1977 Jun;123(3):779-82.

    Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.

    Abstract

    Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.

    PMID:
    860047
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk